Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to -$29.8 million.

  • Cross Country Healthcare's Change in Accured Expenses fell 93573.57% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.5 million, marking a year-over-year increase of 2976.12%. This contributed to the annual value of -$29.8 million for FY2024, which is 7650.05% up from last year.
  • Cross Country Healthcare's Change in Accured Expenses amounted to -$29.8 million in FY2024, which was up 7650.05% from -$126.6 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Change in Accured Expenses peaked at $83.3 million during FY2021, and registered a low of -$126.6 million during FY2023.
  • In the last 5 years, Cross Country Healthcare's Change in Accured Expenses had a median value of $7.2 million in 2020 and averaged $3.4 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 105051.8% in 2021, then plummeted by 25265.37% in 2023.
  • Over the past 5 years, Cross Country Healthcare's Change in Accured Expenses (Annual) stood at $7.2 million in 2020, then soared by 1050.52% to $83.3 million in 2021, then dropped by 0.42% to $82.9 million in 2022, then tumbled by 252.65% to -$126.6 million in 2023, then soared by 76.5% to -$29.8 million in 2024.
  • Its last three reported values are -$29.8 million in FY2024, -$126.6 million for FY2023, and $82.9 million during FY2022.